Literature DB >> 15944760

The role of heparanase in gastrointestinal cancer (Review).

Yoshio Naomoto1, Munenori Takaoka, Takaomi Okawa, Tetsuji Nobuhisa, Mehmet Gunduz, Noriaki Tanaka.   

Abstract

Heparanase is endoglycosidase that degrades heparan sulfate, the main polysaccharide constituent of the extracellular matrix and basement membrane. Heparanase has been thought to have an important role in the process of cancer invasion and metastasis. Recent studies have revealed that heparanase has multifunctional modulatory effects in the progression of cancer cells and the cell-to-extracellular matrix interaction. Our recent research has shown the important roles of heparanase in the progression of esophagus, stomach and colon cancer, and heparanase expression was closely related to the prognosis of gastrointestinal cancer. Therapies targeting heparanase may result in promising tactics in cancer therapies. Heparanase gene silencing and inhibiton of enzymatic activities have potential use as targets for anticancer drug development. Here, we reviewed the role of heparanase in gastrointestinal tract tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944760

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  10 in total

1.  Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice.

Authors:  Immanuel Lerner; Esther Hermano; Eyal Zcharia; Dina Rodkin; Raanan Bulvik; Victoria Doviner; Ariel M Rubinstein; Rivka Ishai-Michaeli; Ruth Atzmon; Yoav Sherman; Amichay Meirovitz; Tamar Peretz; Israel Vlodavsky; Michael Elkin
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

Review 2.  Heparanase: From basic research to therapeutic applications in cancer and inflammation.

Authors:  Israel Vlodavsky; Preeti Singh; Ilanit Boyango; Lilach Gutter-Kapon; Michael Elkin; Ralph D Sanderson; Neta Ilan
Journal:  Drug Resist Updat       Date:  2016-10-06       Impact factor: 18.500

Review 3.  Versatile role of heparanase in inflammation.

Authors:  Rachel Goldberg; Amichay Meirovitz; Nir Hirshoren; Raanan Bulvik; Adi Binder; Ariel M Rubinstein; Michael Elkin
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

4.  Morphologic and molecular events at the invading edge of colorectal carcinomas.

Authors:  Carlos A Rubio
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

5.  Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling.

Authors:  G Chatzinikolaou; D Nikitovic; A Berdiaki; A Zafiropoulos; P Katonis; N K Karamanos; G N Tzanakakis
Journal:  Cell Prolif       Date:  2009-10-21       Impact factor: 6.831

Review 6.  Heparanase in inflammation and inflammation-associated cancer.

Authors:  Amichay Meirovitz; Rachel Goldberg; Adi Binder; Ariel M Rubinstein; Esther Hermano; Michael Elkin
Journal:  FEBS J       Date:  2013-03-04       Impact factor: 5.542

Review 7.  Heparanase enzyme in chronic inflammatory bowel disease and colon cancer.

Authors:  Esther Hermano; Immanuel Lerner; Michael Elkin
Journal:  Cell Mol Life Sci       Date:  2012-02-14       Impact factor: 9.261

8.  Epigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoter.

Authors:  Vinata B Lokeshwar; Pablo Gomez; Mario Kramer; Judith Knapp; Melissa A McCornack; Luis E Lopez; Nevis Fregien; Neetika Dhir; Steve Scherer; David J Klumpp; Murugesan Manoharan; Mark S Soloway; Bal L Lokeshwar
Journal:  J Biol Chem       Date:  2008-08-21       Impact factor: 5.157

9.  Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma.

Authors:  Andreas Bonertz; Jürgen Weitz; Dong-Ho Kim Pietsch; Nuh N Rahbari; Christoph Schlude; Yingzi Ge; Simone Juenger; Israel Vlodavsky; Khashayarsha Khazaie; Dirk Jaeger; Christoph Reissfelder; Dalibor Antolovic; Maximilian Aigner; Moritz Koch; Philipp Beckhove
Journal:  J Clin Invest       Date:  2009-10-05       Impact factor: 14.808

10.  Isolation of a human gallbladder cancer cell clone with high invasive phenotype in vitro and metastatic potential in orthotopic model and inhibition of its invasiveness by heparanase antisense oligodeoxynucleotides.

Authors:  Xin-Zhong Chang; Zhan-Min Wang; Jin-Ming Yu; Fu-Guo Tian; Wei Jin; Yi Zhang; Jie Yu; Lian-Fang Li; Xiao-Feng Liu; Zhi-Wei Li; Zhi-Min Shao
Journal:  Clin Exp Metastasis       Date:  2007-01-27       Impact factor: 4.510

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.